Associations between spirometric measures and exercise capacity in type 2 diabetes

Sun, 2022, IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045, Diabetes Res Clin Pract, 183, 10.1016/j.diabres.2021.109119 Fowler, 2008, Microvascular and macrovascular complications of diabetes, Clin Diabetes, 26, 77, 10.2337/diaclin.26.2.77 Cade, 2008, Diabetes-related microvascular and macrovascular diseases in the physical therapy setting, Phys Ther, 88, 1322, 10.2522/ptj.20080008 Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 Laiteerapong, 2019, The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes & aging study), Diabetes Care, 42, 416, 10.2337/dc17-1144 Richter, 2021, Interactions between insulin and exercise, Biochem J, 478, 3827, 10.1042/BCJ20210185 Díez-Manglano, 2021, Pulmonary function tests in type 2 diabetes: a meta-analysis, ERJ Open Res, 7, 10.1183/23120541.00371-2020 Agrawal, 2015, Correlation between six minute walk test and spirometry in chronic pulmonary disease, J Clin Diagn Res JCDR, 9, OC01 Roshanzamir, 2022, The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis, Ir J Med Sci, 191, 289, 10.1007/s11845-021-02564-9 Santos, 2016, Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction, Eur Respir J, 48 Klinger, 2016, Group III pulmonary hypertension: pulmonary hypertension associated with lung disease: epidemiology, pathophysiology, and treatments, Cardiol Clin, 34, 413, 10.1016/j.ccl.2016.04.003 McDermott, 2014, The six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease, Circulation, 130, 61, 10.1161/CIRCULATIONAHA.114.007002 Hayfron-Benjamin, 2021, Associations between macrovascular and renal microvascular dysfunction in type 2 diabetes and non-diabetes, Microvasc Res. Published online, 8 Khateeb, 2019, Diabetes and lung disease: a neglected relationship, Rev Diabet Stud RDS, 15, 1, 10.1900/RDS.2019.15.1 van den Borst, 2010, Pulmonary function in diabetes: a metaanalysis, Chest, 138, 393, 10.1378/chest.09-2622 Kuziemski, 2019, Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons, BMC Endocr Disord, 19, 2, 10.1186/s12902-018-0328-1 Kassim, 2015, Low forced expiratory volume is associated with earlier death in sickle cell anemia, Blood, 126, 1544, 10.1182/blood-2015-05-644435 Bikov, 2020, FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease, Int J Chronic Obstr Pulm Dis, 15, 1135, 10.2147/COPD.S242809 Hayfron-Benjamin, 2021, Low FEV1 is associated with fetal death in pregnant women with sickle cell disease, Am J Hematol. Published online, 13 2002, ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, 166, 111, 10.1164/ajrccm.166.1.at1102 Graham, 2019, Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement, Am J Respir Crit Care Med, 200, e70, 10.1164/rccm.201908-1590ST Hayfron-Benjamin, 2023, Relationships of blood pressure and control with microvascular dysfunction in type 2 diabetes, Diabetes Epidemiol Manag. Published online, 5 Antwi-Boasiako, 2023, Association between albuminuria and retinal microvascular dysfunction in type 2 diabetes with and without hypertension, Diabetes Epidemiol Manag, 11, 10.1016/j.deman.2023.100139 Whelton, 2022, Harmonization of the American College of Cardiology/American heart association and European society of Cardiology/European society of hypertension blood pressure/hypertension guidelines: comparisons, reflections, and recommendations, Eur Heart J, 43, 3302, 10.1093/eurheartj/ehac432 Passarella, 2018, Hypertension management in diabetes: 2018 update, Diabetes Spectr, 31, 218, 10.2337/ds17-0085 Quanjer, 2012, Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations, Eur Respir J, 40, 1324, 10.1183/09031936.00080312 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J, 26, 948, 10.1183/09031936.05.00035205 Enright, 2003, The six-minute walk test, Respir Care, 48, 783 Saini, 2020, Pulmonary pathology among patients with type 2 diabetes mellitus: an updated systematic Review and meta-analysis, Curr Diabetes Rev, 16, 759, 10.2174/1573399815666190716130324 Abe, 2020, Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction, Cardiovasc Diabetol, 19, 142, 10.1186/s12933-020-01114-4 Ingle, 2006, Diabetes lowers six-minute walk test performance in heart failure, J Am Coll Cardiol, 47, 1909, 10.1016/j.jacc.2006.02.005 Tekerlek, 2020, Exercise capacity and activities of daily living are related in patients with chronic obstructive pulmonary disease, Arch Bronconeumol, 56, 208, 10.1016/j.arbres.2019.06.015 Karanth, 2017, Six minute walk test: a tool for predicting mortality in chronic pulmonary diseases, J Clin Diagn Res JCDR, 11, OC34 Rasekaba, 2009, The six-minute walk test: a useful metric for the cardiopulmonary patient, Intern Med J, 39, 495, 10.1111/j.1445-5994.2008.01880.x Alhamad, 2009, The six-minute walk test in patients with pulmonary sarcoidosis, Ann Thorac Med, 4, 60, 10.4103/1817-1737.49414 Ameri, 2006, Six minute walk test in respiratory diseases: a university hospital experience, Ann Thorac Med, 1, 16, 10.4103/1817-1737.25865 Duong, 2019, Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study, Lancet Global Health, 7, e613, 10.1016/S2214-109X(19)30070-1 Szczesniak, 2017, Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher, J Cyst Fibros Off J Eur Cyst Fibros Soc, 16, 318, 10.1016/j.jcf.2017.01.002 Magnussen, 2017, FEV1 and FVC predict all-cause mortality independent of cardiac function - results from the population-based Gutenberg Health Study, Int J Cardiol, 234, 64, 10.1016/j.ijcard.2017.02.012 Sciurba, 2003, Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length, Am J Respir Crit Care Med, 167, 1522, 10.1164/rccm.200203-166OC